Together, these data suggest that NLRP9 expression is common in both normal and cancer cells of stomach and colon, and that frameshift mutations and expression loss of NLRP9 is frequent in GC and CRC with MSI-H. Here, NLRP9 is linked to colorectal carcinoma.